Cerebral Embolism and MINOCA Secondary to Left Atrial Myxoma after Occlusion of Atrial Septal Defect by Amplatzer Occluder: A Case Report
DOI:
https://doi.org/10.59958/hsf.5803Keywords:
left atrial myxoma, Amplatzer occlude, MINOCA, cerebral embolismAbstract
Primary heart tumors are rare, with atrial myxomas being the most common type. Atrial myxomas can lead to embolisms, heart obstruction, and systemic symptoms. Herein, we report a case of 72-year-old woman who presented with a left atrial myxoma at the atrial septal defect occluder, a new acute cerebral infarction, and MINOCA (myocardial infarction with no obstructive coronary atherosclerosis). Left atrial myxoma is a common primary cardiac tumor; however, left atrial myxomas arising after percutaneous atrial septal defect occlusion are rare. Additionally, the patient presented with a new case of multiple systemic emboli. The patient underwent surgical resection of a left atrial myxoma, occluder, and left atrium, and atrial septal repair, and was discharged with good recovery for outpatient follow-up. The possibility of a cardiac tumor, especially an atrial myxoma, which can lead to a series of complications, should be considered at the closure site after percutaneous atrial septal closure. Therefore, active surgical treatment and long-term follow-up are warranted in such cases.
References
Kuon E, Kreplin M, Weiss W, Dahm JB. The challenge presented by right atrial myxoma. Herz. 2004; 29: 702–709.
Grebenc ML, Rosado-de-Christenson ML, Green CE, Burke AP, Galvin JR. Cardiac myxoma: imaging features in 83 patients. Radiographics. 2002; 22: 673–689.
Li P, Song L, Tao L, Chen X. Right atrial myxoma after Amplatzer atrial septal defect closure device deployment. Interdisciplinary Cardiovascular and Thoracic Surgery. 2023; 36: ivad025.
Matys U, Południewski M, Matlak K, Dobrzycki S, Hirnle T. Large intra-atrial structure 6 years after percutaneous atrial septal defect closure. European Heart Journal of Cardiovascular Imaging. 2016; 17: 831.
Gupta N, Abdelsalam M, Maini B, Mumtaz M, Mandak J. Intra-atrial mass-thrombus versus myxoma, post-amplatzer atrial septal defect closure device deployment. Journal of the American College of Cardiology. 2012; 60: 639.
Mastrangelo A, Olivares P, Giambuzzi I, Muratori M, Alamanni F, Bartorelli AL. Diagnosis and treatment of a left atrial myxoma originating from an atrial septal defect closure device: a case report. European Heart Journal. Case Reports. 2023; 7: ytad258.
Burke A, Virmani R. Tumors of the heart and great vessels, atlas of tumor pathology 1996. Armed Forces Institute of Pathology: Washington DC. 1996.
Pinede L, Duhaut P, Loire R. Clinical presentation of left atrial cardiac myxoma. A series of 112 consecutive cases. Medicine. 2001; 80: 159–172.
Burke A, Virmani R. Pediatric heart tumors. Cardiovascular Pathology. 2008; 17: 193–198.
Acebo E, Val-Bernal JF, Gómez-Román JJ, Revuelta JM. Clinicopathologic study and DNA analysis of 37 cardiac myxomas: a 28-year experience. Chest. 2003; 123: 1379–1385.
L'Angiocola PD, Donati R. Cardiac Masses in Echocardiography: A Pragmatic Review. Journal of Cardiovascular Echography. 2020; 30: 5–14.
Parato VM, Nocco S, Alunni G, Becherini F, Conti S, Cucchini U, et al. Imaging of Cardiac Masses: An Updated Overview. Journal of Cardiovascular Echography. 2022; 32: 65–75.
Pazos-López P, Pozo E, Siqueira ME, García-Lunar I, Cham M, Jacobi A, et al. Value of CMR for the differential diagnosis of cardiac masses. JACC. Cardiovascular Imaging. 2014; 7: 896–905.
Lee EM, Ibrahim ESH, Dudek N, Lu JC, Kalia V, Runge M, et al. Improving MR Image Quality in Patients with Metallic Implants. Radiographics. 2021; 41: E126–E137.
Reynen K. Cardiac myxomas. The New England Journal of Medicine. 1995; 333: 1610–1617.
Sadia H, Oshikoya AF, Sachdev P, Fasoranti-Sowemimo OF, Shawl SH, Kumar K, et al. Atrial Myxoma: An Unusual Etiology of Ischemic Stroke in an Adult Patient. Cureus. 2023; 15: e40599.
Wilkes D, Charitakis K, Basson CT. Inherited disposition to cardiac myxoma development. Nature Reviews. Cancer. 2006; 6: 157–165.
Nitta R, Sakomura Y, Tanimoto K, Hidai T, Kasanuki H, Aomi S, et al. Primary cardiac angiosarcoma of the right atrium undiagnosed by transvenous endocardial tumor biopsy. Internal Medicine (Tokyo, Japan). 1998; 37: 1023–1026.
Miguel CE, Bestetti RB. Primary cardiac lymphoma. International Journal of Cardiology. 2011; 149: 358–363.
Correa R, Salpea P, Stratakis CA. Carney complex: an update. European Journal of Endocrinology. 2015; 173: M85–M97.
Sandrini F, Stratakis C. Clinical and molecular genetics of Carney complex. Molecular Genetics and Metabolism. 2003; 78: 83–92.
Stratakis CA, Kirschner LS, Carney JA. Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. The Journal of Clinical Endocrinology and Metabolism. 2001; 86: 4041–4046.
